a 2023

Exploring patterns in clinical, biological, and molecular data of leukemia patients with CLLue.

REIGL, Tomáš; Veronika NAVRKALOVÁ; Jakub Paweł PORC; Karol PÁL; Kamila STRÁNSKÁ et. al.

Basic information

Original name

Exploring patterns in clinical, biological, and molecular data of leukemia patients with CLLue.

Authors

REIGL, Tomáš; Veronika NAVRKALOVÁ; Jakub Paweł PORC; Karol PÁL; Kamila STRÁNSKÁ; Šárka POSPÍŠILOVÁ and Karla PLEVOVÁ

Edition

CEITEC PhD Conference, 2023

Other information

Language

English

Type of outcome

Konferenční abstrakta

Country of publisher

Czech Republic

Confidentiality degree

is not subject to a state or trade secret

References:

Organization

Středoevropský technologický institut – Repository – Repository

Keywords in English

leukemia; LYmphoid NeXt-Generation Sequencing; LYNX;

Links

LM2018140, research and development project. LX22NPO5102, research and development project. NU21-08-00237, research and development project. NU22-08-00227, research and development project.
Changed: 25/3/2024 03:21, RNDr. Daniel Jakubík

Abstract

V originále

High throughput sequencing data analysis of IG/TR rearranged genes in leukemia clinical research', he has been involved in the development of several software projects, e.g.: LYNX (LYmphoid NeXt-Generation Sequencing) analytical software, CLLue, ARResT/Interrogate, ARResT/Subsets aka Encyclopedia of CLL Subsets. LYNX is a tailor-made bioinformatic tool for a new custom-designed capture-based NGS panel. With this tool, a user can analyze molecular markers, such as gene mutations, copy number variations, antigen receptor rearrangements, and translocations in the most common lymphoid malignancies. CLLue is an interactive web-based tool that allows users to perform a visual exploratory data analysis, identification of important and significant features in given groups based on statistical tests, and de novo clustering on their data.

Files attached